ClinicalIntelPulse
clinicalintelpulse.theaslangroupllc.com · 15 paid endpoints · listed 2026-10-27
ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single trial by NCT id (status, phase, sponsor, enrollment, dates, countries) or search by condition/sponsor with phase and status filters. Typed records straight off the official v2 API — no LLM, no key, public domain.
livelast check 5 days ago
100%valid x402 answers, 72 h
sharedUSDC received on Base, 7 days
17distinct payers, 7 days
64.5score (0-100)
Paid endpoints
| Method | Endpoint | Price | Networks |
|---|---|---|---|
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-check ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single tri | $0.02 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/drug-check What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, | $0.10 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/patient-finder Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), count | $0.10 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/recall-check Is my medication recalled? Checks the FDA enforcement databases (drug AND food — infant formula and supplements are filed under food) for active and past recall | $0.10 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-brief Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes an | $0.10 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/global-trials Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa an | $0.15 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/pipeline-scan Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown an | $0.15 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/failure-analysis Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy wi | $0.20 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/mechanism-map Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first- | $0.20 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioni | $0.20 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, tri | $0.25 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal-lite Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no L | $0.25 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/disease-landscape-lite Deterministic preview of the disease pipeline landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown and a sample of trials straight off Cli | $0.25 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, tr | $0.35 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
| GET | clinicalintelpulse.theaslangroupllc.com/api/clinical/disease-landscape Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, oppo | $0.35 | algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, BNB, Base, eip155:999, Solana, XRPL |
Latest checks
| When | Endpoint | HTTP | ms | Result |
|---|---|---|---|---|
| 5 days ago | clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook | 402 | 375 | valid x402 v2 terms |
Income on Base (7 days)
This provider's payout address is shared by several providers, so its income is not shown as its own.
Is this your API?
Add the live badge to your docs: 
Claim it for free with
<a href="https://logicnodes.io/observatory/p/clinicalintelpulse.theaslangroupllc.com"><img src="https://logicnodes.io/observatory/badge/clinicalintelpulse.theaslangroupllc.com.svg" alt="x402 status"></a>
Claim it for free with
x402_provider_claim (sign with your payout address), and get an alert within minutes when it stops answering with x402_monitor_create ($5 for 30 days). Both work over MCP (https://logicnodes.io/mcp/v2) or POST https://logicnodes.io/v1/tools/<tool>.Income is all USDC received by the provider's payout address on Base, whatever the source. Score: 0-100: 50 x share of checks in the last 72 h that returned valid x402 payment terms + 30 x min(1, log10(1 + USDC received in 7 days) / 4) + 20 x min(1, log10(1 + distinct payers in 7 days) / 3). A provider never checked scores on income only; income is all USDC received by its payout address on Base, whatever the source. JSON: /v1/observatory/providers/clinicalintelpulse.theaslangroupllc.com